177lu-psma-617
novartis
['crpc', 'prostate']
dr. vaishampayan presents an update of the #lupsma #vision trial data based on prior &amp; concurrent treatments #asco22 #prostatecancer anticipate further data of #lupsma + anti-androgen in #mcrpc 
Clinical researcher focused on #ProstateCancer & #immunotherapy. Views are my own & do not represent the National Cancer Institute